Dr. Michael J. Lazar

About Dr. Michael J. Lazar

Michael J. Lazar, M.D. graduated from the University of Arkansas in 1978 and completed postgraduate training in surgery and urology at LSU in 1983. He is four-time board certified by the American Board of Urology and is Managing Physician Director of Santa Rosa Surgical Management Co., LLC, which manages Santa Rosa Memorial Hospital’s Ambulatory Surgery Center. He is also Chairman of the Board of Directors of Redwood Health Services and is a member of the American Urological Association. Dr. Lazar is married with 3 children, and has been active in Boy Scout leadership and coaching soccer. His hobbies include hiking, backpacking, camping, alpine skiing, and the occasional fly-fishing outing. Dr. Lazar also enjoys living in the wine country, which affords cultivation of a love of wine, and proximity to San Francisco allows enjoyment of its theater and fine arts. Dr. Lazar and his staff are proud to be early leaders in the usage of HIFU, a medical procedure that applies high-intensity focused ultrasound energy to locally heat and destroy diseased or damaged tissue with prostate cancer through ablation. Dr. Lazar is working closely with SonaCare to bring this innovative service to Americans with this disease.

Research News: Reduced Risk of Prostate Cancer in Men with Low Testosterone

Men with unusually low amounts of testosterone in their blood are around 20% less likely to develop prostate cancer, according to new research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool. Scientists from the University of Oxford conducted the largest analysis of hormones and prostate cancer risk to date. The study – funded by Cancer Research UK – looked at blood samples from around 19,000 men aged 34-76 years, collected between 1959 and 2004. Of these men 6,900 went on to develop prostate cancer. The researchers divided the 19,000 men into ten groups – ranging from men with the lowest amount of testosterone in their blood to those with the highest, and compared their prostate cancer risk. They found that men [...]

2017-12-13T13:37:18+00:00November 8th, 2017|

New study reveals: Regret is lasting for many men who undergo traditional prostate cancer treatments

Responding to a recent review of patient comments spanning two decades Dr. Michael Lazar of California HIFU talks about the importance of informing prostate cancer patients about all available treatment options. A recent study revealed this month that as they get older, some men who have undergone treatment for prostate cancer come to regret the treatment decisions they made. This study reviewed the survey results of 934 men conducted at intervals of one, two, five, and 15 years after they were treated for prostate cancer. Most of the men (89%) were treated with surgery or radiation. Ultimately, 14.6% of the entire group expressed some regret over treatment results (16.6% of the radiation-treated men, 15% of the surgically-treated men, and 8.2% of the men treated conservatively). [...]

2017-12-13T13:37:18+00:00October 23rd, 2017|

New research could lead to reduction in recurrence of prostate cancer

Recurrence of prostate cancer could be reduced thanks to exciting new discovery Ground breaking research could reduce the recurrence of prostate cancer in males, a new study in the journal Nature Communications reports. During this in depth study, an international team of researchers led by British scientists investigated the impact of anti-hormone therapy on samples taken from patients with prostate cancer. Anti-hormone therapy is a commonly prescribed treatment for cancer of the prostate, which helps to reduce the levels of male hormones -- that stimulate cancer cells to grow -- in the gland. Researchers discovered that an inadvertent consequence of anti-hormone therapy treatment is the activation of the DNA repair enzyme, PARP. The triggering of PARP enables cancer cells to withstand anti-hormone therapy treatment, causing [...]

2017-12-13T13:37:18+00:00October 17th, 2017|

Prostate Cancer News: PSA screening significantly reduces the risk for death

After differences in implementation and settings were accounted for, two important prostate cancer screening trials provide compatible evidence that screening reduces prostate cancer mortality. After differences in implementation and settings were accounted for, two important prostate cancer screening trials provide compatible evidence that screening reduces prostate cancer mortality. These findings suggest that current guidelines recommending against routine PSA-based screening may be revised. However, questions remain about how to implement screening so that the benefits outweigh the potential harms of over-diagnosis and overtreatment. The findings are published in Annals of Internal Medicine. Current guidelines from the United States Preventive Services Task Force (USPSTF) recommend against prostate-specific antigen (PSA) screening for prostate cancer because the evidence for the test showed very low probability that it would reduce [...]

2017-12-13T13:37:19+00:00October 11th, 2017|

Dr. Michael Lazar on September’s Prostate Cancer Awareness Campaign; Why Early Detection Saves Lives

Santa Rosa Urologist and Prostate cancer expert Dr. Michael Lazar provides an overview of prostate cancer screening options, and offers insight on a recent study suggesting that early detection saves lives. September is Prostate Cancer Awareness Month helping to put the spotlight on a very important topic; early treatment options. Second only to skin cancer, prostate cancer is the most common cancer among men in the USA and the second most common cause of cancer related death, lung cancer taking the number one spot. Currently it is estimated that one man in seven will be diagnosed with prostate cancer during his lifetime. Why Early Detection is Important A new study out this month by the American College of Physicians revealed that screening in fact reduces [...]

2017-12-13T13:37:19+00:00September 20th, 2017|

Health Update Interview with Dr. Michael Lazar on iHeartRadio

Dr. Michael Lazar Interview on iHeart Radio Dr. Michael Lazar on HIFU for prostate cancer: In this Interview aired recently on iHeartRadio Dr. Lazar describes the many benefits of HIFU for early diagnosed prostate cancer.  "This is going to be a game-changer, without a doubt," says Dr. Lazar. Listen to the interview by clicking the audio file above. What is High Intensity Focused Ultrasound (HIFU)? HIFU is an FDA approved precise and targeted therapy that reduces the risk of complications caused by surgery and radiation. HIFU uses ultrasound energy, or sound waves, to heat and destroy specifically targeted areas of tissue. During HIFU, the sound waves pass through healthy tissue without causing damage. However, at the focal point of the sound waves (like a [...]

2017-12-13T13:37:19+00:00September 19th, 2017|

Dr. Lazar Health Update Interview on iHeartRadio

Dr. Michael Lazar Interview on iHeart Radio Dr. Michael Lazar on HIFU for prostate cancer: In this Interview aired recently on iHeartRadio Dr. Lazar describes the many benefits of HIFU for early diagnosed prostate cancer.  "This is going to be a game-changer, without a doubt," says Dr. Lazar. Listen to the interview by clicking the audio file above. What is High Intensity Focused Ultrasound (HIFU)? HIFU is an FDA approved precise and targeted therapy that reduces the risk of complications caused by surgery and radiation. HIFU uses ultrasound energy, or sound waves, to heat and destroy specifically targeted areas of tissue. During HIFU, the sound waves pass through healthy tissue without causing damage. However, at the focal point of the sound waves (like a [...]

2017-12-13T13:37:19+00:00September 19th, 2017|

California HIFU Shares Prostate Cancer Facts for National Prostate Cancer Month

September is National Prostate Cancer Awareness Month. Prostate cancer is the most common type of cancer among men in the US, other than skin cancer.  What are the symptoms of prostate cancer? Early prostate cancer usually causes no symptoms. Men who have prostate cancer can be symptom-free for years. But as it grows, prostate cancer can cause some symptoms. Men should see a health care provider if they: Have to urinate often, especially at night Have trouble starting or stopping urine flow Have a weak or slow urine flow Have blood in the urine or semen Feel frequent pain or stiffness in the lower back, hips, or ribs Conditions other than prostate cancer could cause these symptoms. But the only way to know what’s causing them is [...]

2017-12-13T13:37:19+00:00September 12th, 2017|

Dr. Michael Lazar of California HIFU Selected by Sonoma Magazine’s Top Doctors survey

Santa Rosa urologist and prostate cancer expert Dr. Michael Lazar recognized in the field of Urology as one of the best physicians in Sonoma County. Sonoma Magazine’s Top Doctor survey polled Sonoma County doctors and medical specialists for physicians they most often recommend to a loved one. More than 300 professionals are noted in the September issue as “the crème de la crème” in more than 50 categories. Dr. Lazar was recognized by his medical peers in the field of urology, an opinion also supported by Dr. Lazar’s patients. "Dr. Lazar treated my prostate cancer, and I have been cancer free for three years. If you have been diagnosed with PC (prostate cancer) then you're used to seeing many doctors. Dr. Lazar is the first [...]

2017-12-13T13:37:19+00:00September 5th, 2017|